Clinical Trials Search at Vanderbilt-Ingram Cancer Center

APOLLO-B Expanded Access Protocol ALN-TTR02-014 Expanded Access Protocol to Provide Patisiran to Patients with Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) with Cardiomyopathy

Disease Sites:

Not Available

Staging:

Phase II/III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Hung, Rebecca

Participating Institutions:

Vanderbilt University

Open Date:

08-19-2022

Trial Type:

Other

Protocol ID:

CRE-CHF0009

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available